Similar articles

• Assessing PML risk under immunotherapy: if all you have is a hammer, everything looks like a nail.

  Van Schependom J, Gielen J, Laton J, Nagels G. Van Schependom J, et al. Mult Scler. 2016 Mar;22(3):389-92. doi: 10.1177/1352458515596458. Epub 2015 Jul 21. Mult Scler. 2016. PMID: 26199353
• Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients.

  Jordan AL, Yang J, Fisher CJ, Racke MK, Mao-Draayer Y. Jordan AL, et al. Mult Scler. 2022 Jan;28(1):7-15. doi: 10.1177/1352458520949158. Epub 2020 Aug 18. Mult Scler. 2022. PMID: 32808554 Free PMC article. Review.
• Progressive multifocal leukoencephalopathy on dimethyl fumarate with preserved lymphocyte count but deep T-cells exhaustion.

  Garcia J, Hendel-Chavez H, De-Goer MG, L'Honneur AS, Dubessy AL, Taoufik Y, Stankoff B. Garcia J, et al. Mult Scler. 2021 Apr;27(4):640-644. doi: 10.1177/1352458520942201. Epub 2020 Jul 20. Mult Scler. 2021. PMID: 32686582
• Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate.

  Bartsch T, Rempe T, Wrede A, Leypoldt F, Brück W, Adams O, Rohr A, Jansen O, Wüthrich C, Deuschl G, Koralnik IJ. Bartsch T, et al. Ann Neurol. 2015 Oct;78(4):501-14. doi: 10.1002/ana.24471. Epub 2015 Jul 31. Ann Neurol. 2015. PMID: 26150206 Free PMC article. Review.
• Expanding spectrum of opportunistic infections associated with dimethyl fumarate.

  Kim T, Croteau D, Brinker A, Jones DE, Lee PR, Kortepeter CM. Kim T, et al. Mult Scler. 2021 Jul;27(8):1301-1305. doi: 10.1177/1352458520977132. Epub 2020 Dec 10. Mult Scler. 2021. PMID: 33300850